Inventor

Curt A. Dvorak

Inventor
Poway, CA, US

Overview

34→
Patents
2004–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 34 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
10,766,880Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators202010,703,749P2X7 modulators202010,233,173Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators201910,150,765P2X7 modulators201810,112,937P2X7 modulators and methods of use201810,071,988Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators20189,695,183'Substituted 7-azabicycles and their use as orexin receptor modulators'20179,695,149'1,2,6-substituted benzimidazoles as flap modulators'20179,682,972'1,2,5-substituted benzimidazoles as flap modulators'20179,682,971'1,2,5-Substituted benzimidazoles as flap modulators'20179,637,496'Substituted 7-azabicycles and their use as orexin receptor modulators'20179,611,262'Substituted 2-azabicycles and their use as orexin receptor modulators'20179,611,251'Substituted piperidine compounds and their use as orexin receptor modulators'20179,475,819'Substituted 7-azabicycles and their use as orexin receptor modulators'20169,464,084'P2X7 modulators'20169,265,770'1,2,5-substituted benzimidazoles as FLAP modulators'20169,115,117'Substituted piperidine compounds and their use as orexin receptor modulators'20159,089,569'1,2,6-substituted benzimidazoles as flap modulators'20159,067,917'1,2,5-substituted benzimidazoles as FLAP modulators'20159,066,946'P2X7 modulators'20159,062,078'Substituted 7-azabicyles and their use as orexin receptor modulators'20158,952,177'1,2,6-substituted benzimidazoles as FLAP modulators'20158,883,808'Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy'20148,618,288'Pyrimidine compounds as serotonin receptor modulators'20138,338,426'Piperazinyl derivatives useful as modulators of the neuropeptide Y2 receptor'20128,183,239'Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor'20127,897,771'Fused heterocyclic compounds'20117,645,758'Heterocyclic compounds'20107,598,255'Pyrimidine compounds as serotonin receptor modulators'20097,579,470'Fused heterocyclic compounds'20097,504,426'Heterocyclic compounds'20097,402,680'Fused heterocyclic compounds'20087,226,938'Heterocyclic compounds'20076,803,362'Heterocyclic compounds'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2014Based in San Diego, CA, US· patent location history
2007–2020Patents assigned to JANSSEN PHARMACEUTICA NV (32)· patent assignee history
2012–2014Patents assigned to DVORAK CURT A (4)· patent assignee history
2012–2014Patents assigned to RUDOLPH DALE A (3)· patent assignee history
2012–2014Patents assigned to BONAVENTURE PASCAL (2)· patent assignee history
2012Patents assigned to SWANSON DEVIN M (2)· patent assignee history
2012–2020Based in Poway, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN PHARMACEUTICA NV322007–2020
DVORAK CURT Aself42012–2014
RUDOLPH DALE A32012–2014
BONAVENTURE PASCAL22012–2014
SWANSON DEVIN M22012
Locations
LocationPatentsSpan
Poway, California, US232012–2020
San Diego, California, US112004–2014